Global Life Science Ventures Overview
- Investor Type
- Venture Capital
- Status
- Managing
- Professionals
- 2
- Investments
- 57
- Portfolio
- 2
- Exits
- 31
Global Life Science Ventures General Information
Description
Global Life Science Ventures is a venture capital firm focusing on the life science sector. The firm is dedicated to supporting early-stage groups, originating from universities, scientific institutions or industry. The firm was founded in 1996 and is based in Munich, Germany.
Contact Information
Year Founded
1996
Investor Status
Fully Invested, No Longer Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
- Tal 26
- 80331 Munich
- Germany
+49 089 0000000
Global Life Science Ventures Investments (57)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Nabriva Therapeutics | 07-Apr-2015 | Later Stage VC | 00000 | Drug Discovery | Generating Revenue/Not Profitable | 00000 00000000 00.0 |
| 000000 00000000000 | 31-Dec-2014 | 0000 | 0000 | Drug Discovery | Generating Revenue/Not Profitable | |
| 000000 00000000000 | 26-Nov-2014 | 00000 00000 | 00.000 | Drug Discovery | Generating Revenue/Not Profitable | 0000 0ü0000 00.0 |
| 00000000 000000 | 20-Jun-2012 | 00000 00000 | 0000 | Biotechnology | Generating Revenue | 000000 000000000 00.0 |
| 000000 000000 | 03-May-2012 | 00000 00000 | 000.00 | Surgical Devices | Generating Revenue/Not Profitable | |
| 0000000 0000000000 | 01-Mar-2012 | 00000000000 | Drug Discovery | Generating Revenue/Not Profitable | 00000 00000000 00.0 | |
| 0000000 0000000000 | 01-Jul-2011 | 00000000000 | Drug Discovery | Generating Revenue/Not Profitable | 00000 00000000 00.0 | |
| 0000000 0000000000 | 01-Oct-2010 | 00000 00000 | 000.00 | Drug Discovery | Generating Revenue/Not Profitable | 00000 00000000 00.0 |
| Action Pharma | 03-Jun-2010 | Later Stage VC | 00.000 | Drug Discovery | Generating Revenue | |
| Horizon Therapeutics | 17-May-2010 | Early Stage VC | 000.00 | Pharmaceuticals | Profitable |
Global Life Science Ventures Exits (31)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Sequenom | 07-Sep-2016 | Merger/Acquisition | 00000 |
| 0000000 0000000000 | 18-Sep-2015 | 000 | 000.00 |
| 00000000 000000 | 31-Aug-2014 | 000000000000000000 | 00000 |
| 000000 000000 | 17-Jun-2014 | 000 | 0000 |
| 0000000 0000000000 | 09-Jan-2014 | 0000000000: 000000 | |
| 000000 0000000 | 01-Nov-2012 | 000 00 00000000 | |
| 000000 000000 | 15-Jun-2012 | 000000000000000000 | 00000 |
| 000 000000 | 01-Apr-2012 | 00000000 000000 00 | |
| Horizon Therapeutics | 28-Jul-2011 | IPO | 000.00 |
| Spinal Cord Therapeutics | 01-Jul-2011 | Out of Business |
Global Life Science Ventures Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
This information is available in the PitchBook Platform. To explore Global Life Science Ventures‘s full profile, request access.
Request a free trialGlobal Life Science Ventures Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialGlobal Life Science Ventures Team (7)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Hans Küpper Ph.D | Partner | 0 | 0 | Munich, Germany | |
| Peter Reinisch Ph.D | Partner | 0 | 0 | Munich, Germany |